Aemetis Inc Reports Fourth‑Quarter and Full‑Year 2025 Results as Dairy RNG Platform Scales
Aemetis Inc., a biotechnology company listed on the Nasdaq, released its financial results for the fourth quarter and full year of 2025 on March 12, 2026. The company’s primary focus remains the conversion of plant materials into sugars, which can be leveraged in the biochemical and biofuels sectors.
Key Financial Highlights
| Metric | Quarter | Full Year |
|---|---|---|
| Revenue | $53.7 million | – |
| GAAP EPS | –$0.08 | – |
| Revenue variance vs. estimate | Misses by $18.37 million | – |
| EPS variance vs. estimate | Beats by $0.14 | – |
- Revenue for the quarter fell short of analysts’ expectations by $18.37 million.
- GAAP earnings per share was negative, at –$0.08, which nevertheless surpassed consensus forecasts by $0.14.
Operational Context
The company highlighted the scaling of its Dairy Renewable Natural Gas (RNG) platform, which represents a significant component of its strategic expansion. While the financial results indicate continued profitability challenges, the growth in the RNG segment underscores Aemetis’ ongoing investment in sustainable energy solutions.
Market Reaction
Following the announcement, Aemetis’ share price closed at $1.54 on March 10, 2026. The stock had experienced a 52‑week range between $1.22 and $3.66, reflecting volatility amid mixed earnings performance.
Forward Guidance
Aemetis did not provide explicit forward guidance in the released statements. However, the emphasis on the scaling of its RNG operations suggests a continued focus on renewable energy ventures as a potential driver for future revenue growth.
Summary
Aemetis Inc. reported a fourth‑quarter revenue of $53.7 million and a GAAP EPS of –$0.08 for 2025. Although revenue missed analyst expectations, the company’s earnings beat estimates. The expansion of its Dairy RNG platform remains a key operational development, positioning Aemetis within the broader renewable energy landscape.
